Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

China's Coming Big Pharma Boom

http://www.fool.com/investing/general/2013/07/10/chinas-coming-big-pharma-boom.aspx

"The potential of China's pharmaceutical market is hardly a surprise. A report from China's Social Science Academic Press last year estimated that total Chinese pharmaceutical sales will exceed $350 billion by the year 2020. Already, China's the third largest market behind the U.S. and Japan and is expected to surpass its Asian neighbor for the No. 2 spot by 2015."

"Demographics play a big hand in why China's so valuable to big pharma firms. The country's population is aging quickly due to Beijing's one-child law, creating a sizable elderly class to come in future decades that will rely more on pharmaceuticals."